Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVJF) Divestments (2020 - 2025)

Historic Divestments for Teva Pharmaceutical Industries (TEVJF) over the last 6 years, with Q3 2025 value amounting to $8.0 million.

  • Teva Pharmaceutical Industries' Divestments fell 7894.74% to $8.0 million in Q3 2025 from the same period last year, while for Dec 2025 it was $34.0 million, marking a year-over-year decrease of 2093.02%. This contributed to the annual value of $34.0 million for FY2025, which is 2093.02% down from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Divestments of $8.0 million as of Q3 2025, which was down 7894.74% from $9.0 million recorded in Q2 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Divestments peaked at $138.0 million during Q1 2021, and registered a low of $1.0 million during Q2 2024.
  • Over the past 5 years, Teva Pharmaceutical Industries' median Divestments value was $17.0 million (recorded in 2025), while the average stood at $30.8 million.
  • As far as peak fluctuations go, Teva Pharmaceutical Industries' Divestments surged by 220000.0% in 2021, and later crashed by 9821.43% in 2024.
  • Teva Pharmaceutical Industries' Divestments (Quarter) stood at $42.0 million in 2021, then tumbled by 45.24% to $23.0 million in 2022, then crashed by 56.52% to $10.0 million in 2023, then tumbled by 60.0% to $4.0 million in 2024, then surged by 100.0% to $8.0 million in 2025.
  • Its Divestments stands at $8.0 million for Q3 2025, versus $9.0 million for Q2 2025 and $17.0 million for Q1 2025.